Target intelligence / Profile preview

Pyelonephritis-associated pili (Pap)

Target
Pap
Molecular classification
Chaperone-usher fimbriae, Bacterial adhesin, Other
01

Overview

Pyelonephritis-associated pili (Pap), commonly referred to as P fimbriae or P pili, are hair-like, multi-protein appendages found on the surface of uropathogenic Escherichia coli (UPEC). These structures are assembled via the highly conserved chaperone-usher pathway, consisting of a rigid rod composed of PapA subunits and a flexible tip fibrillum containing the PapG adhesin. P fimbriae play a critical role in the pathogenesis of upper urinary tract infections, specifically pyelonephritis, by mediating the adherence of UPEC to Gal(alpha1-4)Gal-specific glycosphingolipid receptors (globoseries glycolipids) on human kidney epithelial cells. This attachment prevents the bacteria from being washed away by urine flow and triggers host inflammatory responses. Because of their essential role in colonization and virulence, P fimbriae are attractive therapeutic targets. Small-molecule inhibitors known as pilicides (such as the ring-fused 2-pyridone derivatives like ec240) have been developed to target the periplasmic chaperone PapD, thereby disrupting pilus biogenesis and preventing bacterial adhesion without directly killing the bacteria, which minimizes the selective pressure for antibiotic resistance.

Other names
P fimbriaeP piliPyelonephritis-associated fimbriaePap fimbriaePap piliE. coli P fimbriaeE. coli P pili
02

Mechanism of action

Inhibition of the chaperone-usher pathway by binding to the periplasmic chaperone (e.g., PapD), thereby preventing chaperone-subunit-usher interactions and disrupting pilus biogenesis, which ultimately blocks bacterial adhesion to host tissues.

03

Biological functions

Cell adhesionHost-pathogen interactionBiofilm formationBacterial colonizationOther
04

Disease associations

InfectionUrinary tract infectionPyelonephritisUrosepsisOther
05

Safety considerations

Disruption of commensal Gram-negative microfloraTarget specificity and selectivityLow solubility and bioavailability of early-generation pilicidesPotential for compensatory upregulation of other fimbrial systems
06

Interacting drugs

Pilicides

4 more in the full profile.

07

Biomarkers

Bacterial loadHemagglutination titerInterleukin-6 (IL-6)Interleukin-8 (IL-8)Neutrophil count

Beyond the preview

Go deeper on Pyelonephritis-associated pili (Pap).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyelonephritis-associated pili (Pap).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call